A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocol
A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocol
Lijun Guo, Zhonghui Jiang, Jingjing Chen, Fangfang Wang et al.
Journal
Frontiers in Cardiovascular Medicine
Topics
Heart Rate Variability and Autonomic Control
article
A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocol
Beijing University of Chinese Medicine (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), National Clinical Research Center for Digestive Diseases (CN), Xiyuan Hospital (CN), National Center for Clinical Laboratories (CN)